Interleukin 7 induces CD4+ T cell-dependent tumor rejection
H Hock, M Dorsch, T Diamantstein, and T Blankenstein
J. Exp. Med. 1991 174: 1291-1298.
[Abstract][PDF]
Determination of the structural basis for selective binding of Epstein- Barr virus to human complement receptor type 2
DR Martin, A Yuryev, KR Kalli, DT Fearon, and JM Ahearn
J. Exp. Med. 1991 174: 1299-1311.
[Abstract][PDF]
Regulated expression and function of CD11c/CD18 integrin on human B lymphocytes. Relation between attachment to fibrinogen and triggering of proliferation through CD11c/CD18
AA Postigo, AL Corbi, F Sanchez-Madrid, and MO de Landazuri
J. Exp. Med. 1991 174: 1313-1322.
[Abstract][PDF]
Platelet-derived growth factor is a potent biologic response modifier of T cells
RA Daynes, T Dowell, and BA Araneo
J. Exp. Med. 1991 174: 1323-1333.
[Abstract][PDF]
B cell tolerance in mice transgenic for anti-CD8 immunoglobulin mu chain
F Brombacher, G Kohler, and H Eibel
J. Exp. Med. 1991 174: 1335-1346.
[Abstract][PDF]
Identification of the motility-related protein (MRP-1), recognized by monoclonal antibody M31-15, which inhibits cell motility
M Miyake, M Koyama, M Seno, and S Ikeyama
J. Exp. Med. 1991 174: 1347-1354.
[Abstract][PDF]
Structure and neutrophil-activating properties of a novel inflammatory peptide (ENA-78) with homology to interleukin 8
A Walz, R Burgener, B Car, M Baggiolini, SL Kunkel, and RM Strieter
J. Exp. Med. 1991 174: 1355-1362.
[Abstract][PDF]
Sphingosine synergistically stimulates tumor necrosis factor alpha- induced prostaglandin E2 production in human fibroblasts
M Candela, SC Barker, and LR Ballou
J. Exp. Med. 1991 174: 1363-1369.
[Abstract][PDF]
T cell receptor genes in a series of class I major histocompatibility complex-restricted cytotoxic T lymphocyte clones specific for a Plasmodium berghei nonapeptide: implications for T cell allelic exclusion and antigen-specific repertoire
JL Casanova, P Romero, C Widmann, P Kourilsky, and JL Maryanski
J. Exp. Med. 1991 174: 1371-1383.
[Abstract][PDF]
Hemolysis of human erythrocytes is a new bioactivity of gangliosides
K Horikawa, H Nakakuma, S Nagakura, M Kawakita, T Kagimoto, M Iwamori, Y Nagai, T Abe, and K Takatsuki
J. Exp. Med. 1991 174: 1385-1391.
[Abstract][PDF]
CD69-mediated pathway of lymphocyte activation: anti-CD69 monoclonal antibodies trigger the cytolytic activity of different lymphoid effector cells with the exception of cytolytic T lymphocytes expressing T cell receptor alpha/beta
A Moretta, A Poggi, D Pende, G Tripodi, AM Orengo, N Pella, R Augugliaro, C Bottino, E Ciccone, and L Moretta
J. Exp. Med. 1991 174: 1393-1398.
[Abstract][PDF]
Role of human decay-accelerating factor in the evasion of Schistosoma mansoni from the complement-mediated killing in vitro [published erratum appears in J Exp Med 1992 Feb 1;175(2):619]
MF Horta, FJ Ramalho-Pinto, and MF] Fatima M$[corrected to Horta
J. Exp. Med. 1991 174: 1399-1406.
[Abstract][PDF]
Signal transduction by the CD2 antigen in T cells and natural killer cells: requirement for expression of a functional T cell receptor or binding of antibody Fc to the Fc receptor, Fc gamma RIIIA (CD16)
LL Spruyt, MJ Glennie, AD Beyers, and AF Williams
J. Exp. Med. 1991 174: 1407-1415.
[Abstract][PDF]
Human immunodeficiency virus type 1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane glycoprotein gp41
CF Ebenbichler, NM Thielens, R Vornhagen, P Marschang, GJ Arlaud, and MP Dierich
J. Exp. Med. 1991 174: 1417-1424.
[Abstract][PDF]
Immune response against lymphocytic choriomeningitis virus infection in mice without CD8 expression
WP Fung-Leung, TM Kundig, RM Zinkernagel, and TW Mak
J. Exp. Med. 1991 174: 1425-1429.
[Abstract][PDF]
Reduction of lupus nephritis in MRL/lpr mice by a bacterial superantigen treatment
C Kim, KA Siminovitch, and A Ochi
J. Exp. Med. 1991 174: 1431-1437.
[Abstract][PDF]
Regulated expression of mouse mammary tumor proviral genes in cells of the B lineage
FE Lund and RB Corley
J. Exp. Med. 1991 174: 1439-1450.
[Abstract][PDF]
Mapping of the C3b-binding site of CR1 and construction of a (CR1)2- F(ab')2 chimeric complement inhibitor
KR Kalli, PH Hsu, TJ Bartow, JM Ahearn, AK Matsumoto, LB Klickstein, and DT Fearon
J. Exp. Med. 1991 174: 1451-1460.
[Abstract][PDF]
The cutaneous lymphocyte antigen is a skin lymphocyte homing receptor for the vascular lectin endothelial cell-leukocyte adhesion molecule 1
EL Berg, T Yoshino, LS Rott, MK Robinson, RA Warnock, TK Kishimoto, LJ Picker, and EC Butcher
J. Exp. Med. 1991 174: 1461-1466.
[Abstract][PDF]
Analysis of T cell receptor beta chains in Lewis rats with experimental allergic encephalomyelitis: conserved complementarity determining region 3
DP Gold, H Offner, D Sun, S Wiley, AA Vandenbark, and DB Wilson
J. Exp. Med. 1991 174: 1467-1476.
[Abstract][PDF]
Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes
JB Weinberg, TJ Matthews, BR Cullen, and MH Malim
J. Exp. Med. 1991 174: 1477-1482.
[Abstract][PDF]
A tumor necrosis factor (TNF) receptor-IgG heavy chain chimeric protein as a bivalent antagonist of TNF activity
K Peppel, D Crawford, and B Beutler
J. Exp. Med. 1991 174: 1483-1489.
[Abstract][PDF]
Gorilla class I major histocompatibility complex alleles: comparison to human and chimpanzee class I
DA Lawlor, E Warren, P Taylor, and P Parham
J. Exp. Med. 1991 174: 1491-1509.
[Abstract][PDF]
Interleukin 7 generates antitumor cytotoxic T lymphocytes against murine sarcomas with efficacy in cellular adoptive immunotherapy
DL Jicha, JJ Mule, and SA Rosenberg
J. Exp. Med. 1991 174: 1511-1515.
[Abstract][PDF]
Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor kappa B binding sites
N Mackman, K Brand, and TS Edgington
J. Exp. Med. 1991 174: 1517-1526.
[Abstract][PDF]
Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytes
JL Frey, T Bino, RR Kantor, DM Segal, SL Giardina, J Roder, S Anderson, and JR Ortaldo
J. Exp. Med. 1991 174: 1527-1536.
[Abstract][PDF]
The genomic structure of human V beta 6 T cell antigen receptor genes [published erratum appears in J Exp Med 1992 Feb 1;175(2):617]
Y Li, P Szabo, and DN Posnett
J. Exp. Med. 1991 174: 1537-1547.
[Abstract][PDF]
Macrophage deactivation by interleukin 10
C Bogdan, Y Vodovotz, and C Nathan
J. Exp. Med. 1991 174: 1549-1555.
[Abstract][PDF]
Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41 [published erratum appears in J Exp Med 1992 Feb 1;175(2):621]
SB Jiang, K Lin, and AR Neurath
J. Exp. Med. 1991 174: 1557-1563.
[Abstract][PDF]
Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen
A Penna, FV Chisari, A Bertoletti, G Missale, P Fowler, T Giuberti, F Fiaccadori, and C Ferrari
J. Exp. Med. 1991 174: 1565-1570.
[Abstract][PDF]
A novel beta 4, alpha 6 integrin-associated epithelial cell antigen involved in natural killer cell and antigen-specific cytotoxic T lymphocyte cytotoxicity
JH Phillips, L McKinney, M Azuma, H Spits, and LL Lanier
J. Exp. Med. 1991 174: 1571-1581.
[Abstract][PDF]
Repression of class II major histocompatibility complex genes by cyclic AMP is mediated by conserved promoter elements
LB Ivashkiv and LH Glimcher
J. Exp. Med. 1991 174: 1583-1592.
[Abstract][PDF]
Limiting dilution analysis of cytotoxic T lymphocytes to human immunodeficiency virus gag antigens in infected persons: in vitro quantitation of effector cell populations with p17 and p24 specificities
RA Koup, CA Pikora, K Luzuriaga, DB Brettler, ES Day, GP Mazzara, and JL Sullivan
J. Exp. Med. 1991 174: 1593-1600.
[Abstract][PDF]
Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men
H Schneider, JM Griffiss, JW Boslego, PJ Hitchcock, KM Zahos, and MA Apicella
J. Exp. Med. 1991 174: 1601-1605.
[Abstract][PDF]
A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex
E Mellins, S Kempin, L Smith, T Monji, and D Pious
J. Exp. Med. 1991 174: 1607-1615.
[Abstract][PDF]
Developmental potential of the earliest precursor cells from the adult mouse thymus
L Wu, M Antica, GR Johnson, R Scollay, and K Shortman
J. Exp. Med. 1991 174: 1617-1627.
[Abstract][PDF]
Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation
JH Cox, JR Bennink, and JW Yewdell
J. Exp. Med. 1991 174: 1629-1637.
[Abstract][PDF]
Molecular characteristics of antibodies bearing an anti-DNA-associated idiotype [published erratum appears in J Exp Med 1992 Jul 1;176(1):309]
A Manheimer-Lory, JB Katz, M Pillinger, C Ghossein, A Smith, and B Diamond
J. Exp. Med. 1991 174: 1639-1652.
[Abstract][PDF]
Strong priming of T cells adoptively transferred into scid mice
GH Sunshine, BL Jimmo, C Ianelli, and L Jarvis
J. Exp. Med. 1991 174: 1653-1656.
[Abstract][PDF]
Conversion of a self peptide sequence into a Kd-restricted neo-antigen by a Tyr substitution
F Healy, C Drouet, P Romero, C Jaulin, and JL Maryanski
J. Exp. Med. 1991 174: 1657-1660.
[Abstract][PDF]
Human immunodeficiency virus infection of eosinophils in human bone marrow cultures
AR Freedman, FM Gibson, SC Fleming, CJ Spry, and GE Griffin
J. Exp. Med. 1991 174: 1661-1664.
[Abstract][PDF]
Fine specificity of cytotoxic T lymphocytes primed in vivo either with virus or synthetic lipopeptide vaccine or primed in vitro with peptide
H Schild, M Norda, K Deres, K Falk, O Rotzschke, KH Wiesmuller, G Jung, and HG Rammensee
J. Exp. Med. 1991 174: 1665-1668.
[Abstract][PDF]
To see an article, click its [Full Text] link.
To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button.
To see one abstract at a time, click its [Abstract] link.
for each issue
